[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368384-105":59,"doc-detail-368384-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploring-vimentin-expression-and-its-protein-interactors-across-diverse-cancer-types-via-the-cancer-genome-atlas-datasets-comprehensive-analysis","Exploring vimentin expression and its protein interactors across diverse cancer types via the cancer genome atlas datasets - comprehensive analysis","","Background: The global burden of cancer is escalating, with millions diagnosed and dying each year, making early detection essential yet often limited to advanced stages. Vimentin (VIM) has emerged as a biomarker with diagnostic and prognostic promise. Materials and methods: VIM expression and promoter methylation are assessed across cancers using TCGA datasets, alongside protein–protein interactions and mutation frequencies via bioinformatics tools. Results and conclusion: VIM is overexpressed in seven cancer types, linked to methylation in specific cancers, with interaction networks supporting roles in proliferation and apoptosis, suggesting therapeutic and diagnostic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-vimentin-expression-and-its-protein-interactors-across-diverse-cancer-types-via-the-cancer-genome-atlas-datasets-comprehensive-analysis/368384/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-vimentin-expression-and-its-protein-interactors-across-diverse-cancer-types-via-the-cancer-genome-atlas-datasets-comprehensive-analysis/368384.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study analyze regarding vimentin in cancer?","Question",{"text":112,"@type":113},"The study evaluates vimentin (VIM) expression and promoter methylation across multiple cancer types, using TCGA datasets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are protein interactions and mutation frequencies obtained?",{"text":117,"@type":113},"Protein–protein interactions and mutation frequencies are analyzed with advanced bioinformatics tools.",{"name":119,"@type":110,"acceptedAnswer":120},"What major conclusion is drawn about VIM’s role in cancer?",{"text":121,"@type":113},"VIM is overexpressed in several cancers and shows links to promoter methylation and interaction networks, supporting its potential as both a therapeutic target and diagnostic marker.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368384,1790730589,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","© 2025 Greater Poland Cancer Centre. Published by Via Medica.  \nAll rights reserved. e-ISSN 2083–4640  \nISSN 1507–1367  \nISSN: 1507–1367  \nRESEARCH PAPER  \nReports of Practical Oncology and Radiotherapy 2025, Volume 30, Number 1, pages: 88–99  \nDOI: 10.5603/rpor.104142  \nSubmitted: 31.05.2024  \nAccepted: 19.12.2024  \nExploring vimentin expression and its protein interactors across diverse cancer types via the cancer genome atlas datasets: a comprehensive analysis  \nMałgorzata Blatkiewicz1, Piotr Białas2, Olga Taryma-Leśniak3, Szymon Mazgaj4, 5, Beata Hukowska-Szematowicz4, 6, Anna Jankowska2  \n1Department of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland 2Chair and Department of Cell Biology, Poznan University of Medical Sciences, Poznań, Poland 3Independent Clinical Epigenetics Laboratory, Pomeranian Medical University, Szczecin, Poland 4Institute of Biology, University of Szczecin, Szczecin, Poland  \n5Department of Blood Preparation, Regional Center for Blood Donation and Blood Treatment in Zielona Góra, Zielona Góra, Poland 6Molecular Biology and Biotechnology Center, University of Szczecin, Szczecin, Poland  \nABSTRACT  \nBackground: The global burden of cancer is escalating, with millions of individuals diagnosed and succumbing to the disease each year. Early detection is crucial for improving patient outcomes, yet many cancers are identified at advanced stages. Vimentin (VIM) has emerged as a promising biomarker with significant diagnostic and prognostic potential.  \nMaterials and methods: This study investigates VIM expression and promoter methylation across various cancers using The Cancer Genome Atlas (TCGA) datasets. Additionally, we analyze protein-protein interactions and mutation frequencies using advanced bioinformatics tools.  \nResults: Our findings reveal that VIM is overexpressed in seven cancer types, including cholangiocarcinoma, glioblastoma multiforme, and breast invasive carcinoma. Notably, VIM expression is correlated with promoter methylation in specific cancers. Furthermore, we identify complex protein interactions involving VIM, highlighting its role in critical cellular processes such as proliferation and apoptosis.  \nConclusion: These insights emphasize Vimentin’s multifaceted role in cancer, suggesting its potential as both a therapeutic target and a diagnostic marker.  \nKeywords: vimentin; TCGA; STRING; expression; methylation; cancer; biomarker Rep Pract Oncol Radiother 2025;30(1):88–99  \nIntroduction  \nThe vimentin gene ( VIM) is a single-copy gene located on the short arm of chromosome 10 (10p12) [1]. VIM encodes for a 57 kDa polypeptide, vimentin (VIM): one of the most widely expressed and highly conserved proteins of the type III inter-  \nmediate filaments (IFs) protein family. Vimentin is expressed in many different tissues and its expression level varies between cell types. The data from the Human Protein Atlas show that human organs, such as ovaries, breasts, lungs, and bone marrow, are characterized by increased VIM expression, while limited gene expression is observed in the stomach,  \nAddress for correspondence: Małgorzata Blatkiewicz, Department of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland; [e-mail: mblatkiewicz@ump.edu.pl](e-mail: mblatkiewicz@ump.edu.pl)  \nThis article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially  \n88 [https://journals.viamedica.pl/rpor](https://journals.viamedica.pl/rpor)  \nrectum, and liver [2] . Increased level of the VIM was also shown in activated macrophages, in contrast to limited expression of vimentin in T and B lymphocytes and a lack of its expression in Burkitt’s lymphoma cell lines [3] .  \nThe primary biological fun","cbCaikHrfraIv0OF","https://ap.wps.com/l/cbCaikHrfraIv0OF","pdf",926214,12,"English","# Abstract\n## Background\n## Materials and methods\n## Results\n## Conclusion\n# Introduction\n## Vimentin gene and protein features\n## Cellular and extracellular functions\n## Vimentin in cancer progression and EMT","[{\"question\":\"What does the study analyze regarding vimentin in cancer?\",\"answer\":\"The study evaluates vimentin (VIM) expression and promoter methylation across multiple cancer types, using TCGA datasets.\"},{\"question\":\"How are protein interactions and mutation frequencies obtained?\",\"answer\":\"Protein–protein interactions and mutation frequencies are analyzed with advanced bioinformatics tools.\"},{\"question\":\"What major conclusion is drawn about VIM’s role in cancer?\",\"answer\":\"VIM is overexpressed in several cancers and shows links to promoter methylation and interaction networks, supporting its potential as both a therapeutic target and diagnostic marker.\"}]","Exploring vimentin expression and its protein interactors across diverse cancer types via the cancer genome atlas datasets - comprehensive analysis | PDF",1790176658,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edefe064a2d341acfba800fe5df8d11c.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f979d6957261b20415f4bdb0f9d1beef.webp",982,1389,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48564a0d7f285f1af2927d7e3c06f1a7.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd54eeb6fc2fbc43231f9d1c015405e8.webp",980,1386]